Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Glucose** is the naturally occurring D-enantiomer of glucose, commonly termed **dextrose** in pharmaceutical products. It is a monosaccharide carbohydrate used medicinally to promptly raise blood glucose in acute hypoglycemia and, in intravenous solutions, to supply carbohydrate calories and water or as part of parenteral nutrition. It acts as a metabolic substrate rather than through a discrete receptor-mediated pharmacologic target. U.S. dextrose injection labels describe approved use for treatment of hypoglycemia and as a source of calories in patients requiring intravenous nutritional support. ([dailymed.nlm.nih.gov](https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=66713d9c-f404-4ec8-e053-2a91aa0a620a))
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on glucose.